AXISCADES Tech. (AXISCADES)
Fast GrowerFairStock Score: 19/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,484.8 |
| Market Cap | ₹6,315.37 Cr |
| P/E Ratio | 88.49 |
| ROCE | 13.76% |
| ROE | 7.8% |
| Dividend Yield | 0% |
| Profit Growth | -311.45% |
| Debt/Equity | 0.53 |
| Sales Growth | -93.23% |
| Promoter Holding | 58.05% |
| 52-Week Range | ₹1,063.3 — ₹2,210 |
| Sector | Aerospace & Defense |
| Book Value | ₹170.79 |
Strengths
- Revenue growth of 25.01% and profit growth of 110.65% show strong momentum
- PEG ratio of 0.81 suggests valuation is reasonable relative to near-term growth
- Piotroski F-Score of 7/9 indicates solid fundamental health
- Promoter holding of 58.05% aligns owner interests
- Moderate debt-to-equity of 0.37 provides balance sheet comfort
Concerns
- P/E of 54.77 and P/B of 23.00 leave little margin of safety
- ROE of 7.80% is weak relative to the premium valuation
- Zero dividend yield means shareholders rely entirely on price appreciation
- Latest quarter net margin of about 8% is modest for such a high multiple
AI Analysis
Let me start with what I know: the price is ₹2,000.65, but value is what I get. At a P/E of 54.77 and a P/B of 23.00, the market is paying a rich price for this aerospace and defense business. Book value is only ₹86.97, yet ROE is just 7.80% — that tells me the return on equity is not justifying the premium. ROCE at 13.76% is respectable, and debt-to-equity of 0.37 is manageable, so the balance sheet is not reckless. The growth figures catch my eye: sales up 25.01% and profit up 110.65%, with a PEG of 0.81. That looks like a fast grower, and the Piotroski F-Score of 7/9 suggests fundamentals are improving, not deteriorating. Promoter holding of 58.05% is a good sign; owners have skin in the game. But I worry about paying 54 times earnings for a company whose latest quarter delivered ₹343 Cr sales and ₹28 Cr net profit — that is roughly an 8% margin, decent but not spectacular. There is zero dividend yield, so the retail investor gets no cash while waiting for growth. The 52-week range of ₹1,063 to ₹2,210 shows the stock has already run hard; at ₹2,000, I am near the top, not at a bargain. Graham would say the margin of safety is thin. If growth slows or margins compress, the multiple will hurt. I would not call this a stalwart yet; it is a promising grower, but the price already celebrates tomorrow. I need proof that orders, execution, and returns on equity keep improving before I pay this valuation.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer